Empagliflozin recalls
The FDA has published 6 recalls involving Empagliflozin since 2018. The latest was reported on 3 Jan 2024. Most were for manufacturing (cgmp) deviations. Cardinal Health has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls6since 2018
Last 12 months0reported
Class I00% of total
Ongoing0latest 3 Jan 2024
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 6 100%Class III 0 0%
Why empagliflozin is recalled
Companies
Brands
By year
All empagliflozin recalls, newest first
6 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Jardiance (empagliflozin tablets), 25 mg (3 blister cards with each) recalledJardiance | Cardinal Healthcare | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Jardiance (Empagliflozin) recalled by Boehringer IngelheimJardiance | Boehringer Ingelheim Pharmaceuticals | Packaging Defects | Nationwide |
| Drug | CLASS II | Synjardy XR (empagliflozin and metformin hydrochloride recalledSynjardy | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
| Drug | CLASS II | Glyxambi (empagliflozin and linagliptin) Tablets 25 mg/5 mg recalledGlyxambi | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
| Drug | CLASS II | Synjardy XR (empagliflozin and metformin) hydrochloride recalledSynjardy | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
| Drug | CLASS II | Synjardy (empagliflozin and metformin hydrochloride) Tablets recalledSynjardy | Boehringer Ingelheim Pharmaceuticals | Other | Nationwide |
Should you stop taking Empagliflozin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.